Literature DB >> 20685985

Biochemical and functional interaction of disrupted-in-schizophrenia 1 and amyloid precursor protein regulates neuronal migration during mammalian cortical development.

Tracy L Young-Pearse1, Seiyam Suth, Eric S Luth, Akira Sawa, Dennis J Selkoe.   

Abstract

Although clinically distinct, schizophrenia and Alzheimer's disease are common and devastating disorders that profoundly impair cognitive function. For Alzheimer's disease, key mechanistic insights have emerged from genetic studies that identified causative mutations in amyloid precursor protein (APP) and presenilin. Several genes have been associated with schizophrenia and other major psychoses, and understanding their normal functions will help elucidate the underlying causes of these disorders. One such gene is disrupted-in-schizophrenia 1 (DISC1). DISC1 and APP have been implicated separately in cortical development, with each having roles in both neuronal migration and neurite outgrowth. Here, we report a previously unrecognized biochemical and functional interaction between DISC1 and APP. Using in utero electroporation in the living rat brain, we show that DISC1 acts downstream of APP and Disabled-1 to regulate cortical precursor cell migration. Specifically, overexpression of DISC1 rescues the migration defect caused by a loss of APP expression. Moreover, knockdown of APP in cultured embryonic neurons results in altered subcellular localization of DISC1. Using transfected cells and normal brain tissue, we show that APP and DISC1 coimmunoprecipitate and that the intracellular domain of APP interacts with the N-terminal domain of DISC1. Based on these findings, we hypothesize that the APP cytoplasmic region transiently interacts with DISC1 to help regulate the translocation of DISC1 to the centrosome, where it plays a key role in controlling neuronal migration during cortical development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685985      PMCID: PMC3018837          DOI: 10.1523/JNEUROSCI.1445-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects.

Authors:  William Hennah; Teppo Varilo; Marjo Kestilä; Tiina Paunio; Ritva Arajärvi; Jari Haukka; Alex Parker; Rory Martin; Steve Levitzky; Timo Partonen; Joanne Meyer; Jouko Lönnqvist; Leena Peltonen; Jesper Ekelund
Journal:  Hum Mol Genet       Date:  2003-10-07       Impact factor: 6.150

2.  Replication of 1q42 linkage in Finnish schizophrenia pedigrees.

Authors:  J Ekelund; W Hennah; T Hiekkalinna; A Parker; J Meyer; J Lönnqvist; L Peltonen
Journal:  Mol Psychiatry       Date:  2004-11       Impact factor: 15.992

3.  Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2.

Authors:  M Trommsdorff; M Gotthardt; T Hiesberger; J Shelton; W Stockinger; J Nimpf; R E Hammer; J A Richardson; J Herz
Journal:  Cell       Date:  1999-06-11       Impact factor: 41.582

4.  Disruption of two novel genes by a translocation co-segregating with schizophrenia.

Authors:  J K Millar; J C Wilson-Annan; S Anderson; S Christie; M S Taylor; C A Semple; R S Devon; D M St Clair; W J Muir; D H Blackwood; D J Porteous
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

5.  The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids.

Authors:  B W Howell; L M Lanier; R Frank; F B Gertler; J A Cooper
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

6.  Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder.

Authors:  Colin A Hodgkinson; David Goldman; Judith Jaeger; Shalini Persaud; John M Kane; Robert H Lipsky; Anil K Malhotra
Journal:  Am J Hum Genet       Date:  2004-09-22       Impact factor: 11.025

Review 7.  Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1.

Authors:  Hanna Jaaro-Peled; Akiko Hayashi-Takagi; Saurav Seshadri; Atsushi Kamiya; Nicholas J Brandon; Akira Sawa
Journal:  Trends Neurosci       Date:  2009-08-26       Impact factor: 13.837

8.  Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders.

Authors:  N J Brandon; E J Handford; I Schurov; J-C Rain; M Pelling; B Duran-Jimeniz; L M Camargo; K R Oliver; D Beher; M S Shearman; P J Whiting
Journal:  Mol Cell Neurosci       Date:  2004-01       Impact factor: 4.314

Review 9.  Proteolytic processing and cell biological functions of the amyloid precursor protein.

Authors:  B De Strooper; W Annaert
Journal:  J Cell Sci       Date:  2000-06       Impact factor: 5.285

10.  Lis1 and doublecortin function with dynein to mediate coupling of the nucleus to the centrosome in neuronal migration.

Authors:  Teruyuki Tanaka; Finley F Serneo; Christine Higgins; Michael J Gambello; Anthony Wynshaw-Boris; Joseph G Gleeson
Journal:  J Cell Biol       Date:  2004-06-01       Impact factor: 10.539

View more
  50 in total

Review 1.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

Review 2.  DISC1 at 10: connecting psychiatric genetics and neuroscience.

Authors:  David J Porteous; J Kirsty Millar; Nicholas J Brandon; Akira Sawa
Journal:  Trends Mol Med       Date:  2011-10-19       Impact factor: 11.951

3.  Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels.

Authors:  Qing-Shan Deng; Xing-Yu Dong; Hao Wu; Wang Wang; Zhao-Tao Wang; Jian-Wei Zhu; Chun-Feng Liu; Wei-Qiang Jia; Yan Zhang; Melitta Schachner; Quan-Hong Ma; Ru-Xiang Xu
Journal:  Neuropsychopharmacology       Date:  2015-06-11       Impact factor: 7.853

4.  Pancortins interact with amyloid precursor protein and modulate cortical cell migration.

Authors:  Heather C Rice; Matthew Townsend; Jilin Bai; Seiyam Suth; William Cavanaugh; Dennis J Selkoe; Tracy L Young-Pearse
Journal:  Development       Date:  2012-09-19       Impact factor: 6.868

Review 5.  In utero electroporation as a tool for genetic manipulation in vivo to study psychiatric disorders: from genes to circuits and behaviors.

Authors:  Yu Taniguchi; Tracy Young-Pearse; Akira Sawa; Atsushi Kamiya
Journal:  Neuroscientist       Date:  2011-05-05       Impact factor: 7.519

Review 6.  The Roles of the Stem Cell-Controlling Sox2 Transcription Factor: from Neuroectoderm Development to Alzheimer's Disease?

Authors:  Golmaryam Sarlak; Bruno Vincent
Journal:  Mol Neurobiol       Date:  2015-02-18       Impact factor: 5.590

Review 7.  Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.

Authors:  Huntington Potter; Antoneta Granic; Julbert Caneus
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

8.  Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder.

Authors:  Joel Jakobsson; Henrik Zetterberg; Kaj Blennow; Carl Johan Ekman; Anette G M Johansson; Mikael Landén
Journal:  Neuropsychopharmacology       Date:  2012-11-06       Impact factor: 7.853

Review 9.  DISC1 is a coordinator of intracellular trafficking to shape neuronal development and connectivity.

Authors:  M J Devine; R Norkett; J T Kittler
Journal:  J Physiol       Date:  2016-06-12       Impact factor: 5.182

10.  DISC1 as a Possible Genetic Contribution to Opioid Dependence in a Polish Sample.

Authors:  Sylwia Fudalej; Andrzej Jakubczyk; Maciej Kopera; Jerzy Piwonski; Wojciech Bielecki; Wojciech Drygas; Krystyna Wasilewska; Mark Ilgen; Amy Bohnert; Kristen Barry; Rafał Płoski; Frederic C Blow; Marcin Wojnar
Journal:  J Stud Alcohol Drugs       Date:  2016-03       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.